Nuclear Medicine & Radio Pharmaceuticals Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NUCLEAR MEDICINE & RADIO PHARMACEUTICALS INDUSTRY

2.1 Summary about Nuclear Medicine & Radio Pharmaceuticals Industry

2.2 Nuclear Medicine & Radio Pharmaceuticals Market Trends

2.2.1 Nuclear Medicine & Radio Pharmaceuticals Production & Consumption Trends

2.2.2 Nuclear Medicine & Radio Pharmaceuticals Demand Structure Trends

2.3 Nuclear Medicine & Radio Pharmaceuticals Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

4.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Diagnostic Applications: SPECT, PET.

4.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

5.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Diagnostic Applications: SPECT, PET.

5.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

6.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Diagnostic Applications: SPECT, PET.

6.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

7.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Diagnostic Applications: SPECT, PET.

7.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

8.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Diagnostic Applications: SPECT, PET.

8.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

9.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Diagnostic Applications: SPECT, PET.

9.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 GE Healthcare

10.1.2 Philips Healthcare

10.1.3 Siemens Healthcare

10.1.4 Toshiba

10.1.5 Hitachi

10.1.6 Carestream

10.1.7 Esaote

10.1.8 Shimadzu

10.1.9 TriFoil Imaging

10.1.10 Biosensors International Group, Ltd

10.2 Nuclear Medicine & Radio Pharmaceuticals Sales Date of Major Players (2017-2020e)

10.2.1 GE Healthcare

10.2.2 Philips Healthcare

10.2.3 Siemens Healthcare

10.2.4 Toshiba

10.2.5 Hitachi

10.2.6 Carestream

10.2.7 Esaote

10.2.8 Shimadzu

10.2.9 TriFoil Imaging

10.2.10 Biosensors International Group, Ltd

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Nuclear Medicine & Radio Pharmaceuticals Product Type Overview

Table Nuclear Medicine & Radio Pharmaceuticals Product Type Market Share List

Table Nuclear Medicine & Radio Pharmaceuticals Product Type of Major Players

Table Brief Introduction of GE Healthcare

Table Brief Introduction of Philips Healthcare

Table Brief Introduction of Siemens Healthcare

Table Brief Introduction of Toshiba

Table Brief Introduction of Hitachi

Table Brief Introduction of Carestream

Table Brief Introduction of Esaote

Table Brief Introduction of Shimadzu

Table Brief Introduction of TriFoil Imaging

Table Brief Introduction of Biosensors International Group, Ltd

Table Products & Services of GE Healthcare

Table Products & Services of Philips Healthcare

Table Products & Services of Siemens Healthcare

Table Products & Services of Toshiba

Table Products & Services of Hitachi

Table Products & Services of Carestream

Table Products & Services of Esaote

Table Products & Services of Shimadzu

Table Products & Services of TriFoil Imaging

Table Products & Services of Biosensors International Group, Ltd

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast (Million USD) by Region 2021f-2026f

Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Nuclear Medicine & Radio Pharmaceuticals Market Forecast (Million USD) Share by Demand 2021f-2026f